Contactless Human-Machine-Interface Based on Magnetometers for Consumer Applications

May 18, 2026 updated by: Robert Bosch GmbH
This study explores the use of novel, highly sensitive quantum-based magnetometers for creating a contactless human-machine interface for consumer applications. These sensors can detect extremely weak biomagnetic fields, such as those from the brain's neural activity (magnetoencephalography), at room temperature. The research aims to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case. The results will serve as a foundation for developing future applications.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • Baden-Wurttemberg
      • Renningen, Baden-Wurttemberg, Germany, 71272
        • Robert Bosch Gmbh, Corporate Sector Research and Advance Engineering

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Are at least 18 years of age.
  • Are right-handed with normal or corrected vision.
  • Are employees of Robert Bosch GmbH and are participating in this study during their working hours.
  • They have no acute physical or psychological impairments. They are self-sufficient and have the legal capacity to consent.
  • They have provided written consent to participate in the study and for their data to be processed, and have not withdrawn this consent.

Exclusion Criteria:

  • Pregnancy
  • Known cardiological, neurological, or psychiatric pre-existing conditions, especially epilepsy, claustrophobia, agoraphobia.
  • Metal-containing prostheses or pacemakers.
  • Inability to lie still for several minutes.
  • Body weight of more than 99 kg.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motor imagery and Steady State Evoked Potentials
internal simulation of an arm movement without execution and periodic visual stimulus
Device: Magnetoencephalography using quantum-based magnetometers
Detection of extremely weak biomagnetic fields from the brain's neural activity (magnetoencephalography), to quantify interfering biological signals and evaluate the system's performance in detecting user intention for a simple use case.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Amplitudes of acquired MEG signals
Time Frame: 1 hour
1 hour

Secondary Outcome Measures

Outcome Measure
Time Frame
Ratio of MEG signal to ambient noise level
Time Frame: 1 hour
1 hour
Modulation of magnetic power spectral density
Time Frame: 1 hour
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Robert Bosch GmbH

Investigators

  • Principal Investigator: Eckhard Wehrse, MD, Robert Bosch GmbH

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 21, 2024

Primary Completion (Actual)

May 1, 2026

Study Completion (Actual)

May 1, 2026

Study Registration Dates

First Submitted

February 11, 2026

First Submitted That Met QC Criteria

March 11, 2026

First Posted (Actual)

March 12, 2026

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HMI-OPM-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe